Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep;17(14):1595-605.
doi: 10.2217/pgs-2016-0039. Epub 2016 Aug 17.

A review of consent practices and perspectives for pharmacogenetic testing

Susanne B Haga  1 , Rachel Mills  1
Affiliations
Review

A review of consent practices and perspectives for pharmacogenetic testing

Susanne B Haga et al. Pharmacogenomics. 2016 Sep.

Abstract

Aim: We aimed to understand consent practices for pharmacogenetic (PGx) testing.

Methods: We conducted a literature review and analysis of consent forms from clinical laboratories offering PGx testing.

Results: Our review of the literature shows a lack of consensus about the need for and type of informed consent for PGx testing. We identified 35 companies offering PGx testing and were able to confirm consent practices for 22 of those. We found a range of variability in the consent practices regarding the consent approach and information disclosed.

Conclusion: Variability in the consent practices among laboratories offering PGx testing mirrors the ambiguous practices and recommendations reported in the literature. Establishing a minimal set of information to be disclosed to patients may help address the disparities in consent practice.

Keywords: communication; consent; pharmacogenetic testing; pharmacogenetics.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure SB Haga serves as a consultant to Mako Medical Laboratories (Raleigh, NC, USA) and the Inova Translational Medicine Institute (Falls Church, VA, USA). The authors are partly supported by the US NIH (1R01GM081416). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Haga SB, Moaddeb J. Comparison of delivery strategies for pharmacogenetic testing services. Pharmacogenet. Genomics. 2014;24(3):139–145. - PMC - PubMed
    1. Dunnenberger HM, Crews KR, Hoffman JM, et al. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu. Rev. Pharmacol. Toxicol. 2015;55:89–106. - PMC - PubMed
    1. Institute of Medicine. Crossing the Quality Chasm: a New Health System for the 21st Century. National Academy Press; Washington, DC, USA: 2001. - PubMed
    1. American Medical Association. Opinion 8.08 - Informed Consent. www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical...
    1. Coleman CH, Selgelid MJ, Reis A, Reichman LB, Jaramillo E. The role of informed consent in tuberculosis testing and screening. Eur. Respir. J. 2012;39(5):1057–1059. - PubMed

Publication types

LinkOut - more resources